WR1 General Discussion, page-22127

With feelings running a bit hot today and several planning to bombard Chris with emails it might be a good idea if I attempted to perhaps answer some of other posters' questions here to save that. Earlier this week I had some communication with him and the following is the gist of what I was told: in my own words [my own comments in brackets]

They prefer not to release several random assays [which they very possibly have on hand at present but which was not specifically stated] and instead wait until they can deliver a 'material' announcement in this current market state. [To me this makes sense because it's pretty obvious anything less than some of our better intercepts are not likely to boost the SP apart from giving traders a few cents gain before a retrace. Currently buyers are looking for AZS/WC8-type 100m hits.]

Labs have consistently disappointed from the start and there has so far been no real improvement from the new Radisson lab, though Chris is optimistic that'll change once it fully ramps up.

Chris is sticking by his previous guidance for release of the MRE [Q1 I believe it was] even if assay delivery times are slower than expected. [As I suggested the other day, if they were determined to stick to Q1 and assays were not complete they could always run with whatever they did have and make it slightly smaller - with an upgrade later.]